HUMAN FIBROBLAST GROWTH FACTOR 1 (FGF-1) MUTEINS, THEIR DIMERS AND USES

The present invention relates to human fibroblast growth factor (FGF-1) muteins having decreased mitogenicity, dimers of human FGF-1 muteins, as well as such human FGF-1 muteins and dimers of such muteins for use in reducing blood glucose level, particularly for use in the treatment of diabetes.

Saved in:
Bibliographic Details
Main Authors KROWARSCH, Daniel Rafal, ZAKRZEWSKA, Malgorzata Urszula, JANISZEWSKI, Michal Mieczyslaw, DRZAZGA, Ewa, CZYREK, Aleksandra Anna, PIECZYKOLAN, Jerzy Szczepan, BAZYDLO-GUZENDA, Katarzyna, BUDA, Pawel, WIECZOREK, Maciej, OTLEWSKI, Jacek Józef
Format Patent
LanguageEnglish
French
German
Published 10.04.2024
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to human fibroblast growth factor (FGF-1) muteins having decreased mitogenicity, dimers of human FGF-1 muteins, as well as such human FGF-1 muteins and dimers of such muteins for use in reducing blood glucose level, particularly for use in the treatment of diabetes.
Bibliography:Application Number: EP20220743606